Prepared By R.R. Donnelley Financial -- Form 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): 12/05/2011
Stereotaxis, Inc.
(Exact name of registrant as specified in its charter)
Commission File Number: 000-50884
|
Delaware
|
|
94-3120386
|
|
(State or other jurisdiction of
|
|
(IRS Employer
|
|
incorporation)
|
|
Identification No.)
|
4320 Forest Park Avenue, Suite 100, St. Louis, MO 63108
(Address of principal executive offices, including zip code)
314-678-6100
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01. Other Events
On December 5, 2011, Stereotaxis, Inc. (the "Company") satisfied the closing conditions pursuant to the royalty financing agreement with Cowen Healthcare Royalty Partners II, L.P. ("Cowen Royalty") dated November 30, 2011, and the Company received $15 million in proceeds from Cowen Royalty.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
|
|
|
|
|
Stereotaxis, Inc.
|
|
|
|
|
|
Date: December 09, 2011
|
|
|
|
By:
|
|
/s/ Samuel W. Duggan II
|
|
|
|
|
|
|
|
|
|
Samuel W. Duggan II
|
|
|
|
|
|
|
|
|
|
Chief Financial Officer
|
|
|
|
|